ライフサイエンスコーパス: Gbetagamma

1 gamma subunits of heterotrimeric G-proteins (Gbetagamma).

2 re identified as the primary binding site of Gbetagamma.

3 able of interacting with the binding site of Gbetagamma.

4 dividually necessary for TRPM3 inhibition by Gbetagamma.

5 full-length AC5 depend on multiple sites on Gbetagamma.

6 Rac1 by inhibiting PREX2 binding to PIP3 and Gbetagamma.

7 d a modest activation by GPCR or coexpressed Gbetagamma.

8 1(GDP) closes the channel through removal of Gbetagamma.

9 tinct from the site of channel activation by Gbetagamma.

10 ystal structure of this domain together with Gbetagamma.

11 arly to Galpha(i2)QL could not interact with Gbetagamma.

12 s were essential for stable interaction with Gbetagamma.

13 )-coupled receptors also influence TRPM3 via Gbetagamma.

14 dicating that this effect was independent of Gbetagamma.

15 empower "stand-alone control" of PLCbeta by Gbetagamma.

16 s treated with a small-molecule inhibitor of Gbetagamma.

17 PAR2 activation induced translocation of Gbetagamma, a PKD activator, to the Golgi apparatus, det

18 We hypothesized that Gbetagamma/AC5 interactions involving inactive heterotri

19 ement of the PH domain in PLC-beta modulates Gbetagamma access to its binding site.

20 icity of Galpha subunits, the specificity of Gbetagammas activated by a given GPCR and that activate

21 homo-tetramers that Na(+) binding increases Gbetagamma affinity and thereby increases the GIRK4 resp

22 rther amplifies opening mostly by increasing Gbetagamma affinity.

23 expression and was blocked by inhibitors of Gbetagamma, Akt, NOS, and soluble guanylate cyclase.

24 to interact with the beta2AR to activate the Gbetagamma-Akt-eNOS-sGC pathway to induce MB.

25 t not MT(2) A peptide acting to release free Gbetagamma also activates hSlo1 in a MT(1)-dependent and

26 Gbetagamma also binds the C1/C2 catalytic domains of AC5

27 indicate that G1-dCT is a crucial part of a Gbetagamma anchoring site of GIRK1-containing channels,

28 Consistent with an integrated response, Gbetagamma and AKT kinase were associated with active SD

29 ration, suggesting that GRK2 is recruited to Gbetagamma and alpha(2A)AR with EC50 values of 15 nM and

30 he model's predictions on the role of CaMKII-Gbetagamma and CaN-Gbetagamma interactions in mediating

31 he cleaved GIRK2 displays reduced binding to Gbetagamma and cannot coassemble with GIRK1.

32 of residues relevant for interaction between Gbetagamma and certain downstream effectors (resulting i

33 pendent activation of GIRK1/2 by coexpressed Gbetagamma and fully accounts for the inverse Ibasal-Ra

34 morphology and are stimulated downstream of Gbetagamma and Galpha(12/13) or Galpha(q), respectively.

35 s a sensitive bidirectional detector of both Gbetagamma and Galpha.

36 nd the lipid bilayer system, we characterize Gbetagamma and Na(+) regulation of GIRK1/4 hetero-tetram

37 at GIRK2, through its dual responsiveness to Gbetagamma and Na(+), mediates a form of neuronal inhibi

38 Using a Venus-tagged Gbetagamma and nanoluciferase-tagged truncated G protein

39 docking sites for GalphaiGDP independent of Gbetagamma and stabilize the GDP-bound conformation of G

40 between cerulean fluorescent protein-labeled Gbetagamma and the Alexa Fluor 594-labeled PLC-beta plec

41 needed for cell-cell fusion, is mediated by Gbetagamma and the mitogen-activated protein kinase (MAP

42 hat modify the activity of either Galphao or Gbetagamma and then observing their effects on the basal

43 WIN55,212-2 for Galphai/o, Galphas, Galphaq, Gbetagamma, and beta-arrestin1 signaling following treat

44 activated by the second messengers PIP3 and Gbetagamma, and further regulation of PREX GEF activity

45 Inhibitors of PKD, Gbetagamma, and protein translation inhibited recovery o

46 xist either as monomers or in a complex with Gbetagamma, and the details of combinatorial genetic and

47 and the increase in eNOS phosphorylation was Gbetagamma- and Akt-dependent.

48 The increase in Akt phosphorylation was Gbetagamma- and PI3K-dependent, and the increase in eNOS

49 Rluc BRET was not altered by PT treatment or Gbetagamma antagonists.

50 l predicts that both [Formula: see text] and Gbetagamma are essential for direction sensing, in that

51 pled receptor signaling and the discovery of Gbetagamma as a critical signaling component of the hete

52 Two key intermediates in the Gbetagamma assembly process, the Gbeta-CCT and the PhLP1

53 an isoform-specific mechanism in which bound Gbetagamma at the AC5NT is ideally situated for spatiote

54 Blocking Gbetagamma at the Golgi inhibited ET-1-dependent PI4P de

55 Finally, blocking Gbetagamma at the Golgi or PM blocked ET-1-dependent car

56 lated by the synergistic binding of PIP3 and Gbetagamma at the plasma membrane.

57 nical murine models of cancer, inhibition of Gbetagamma attenuates tumor growth, whereas in cancer pa

58 2-AG and AEA displayed Galphai/o/Gbetagamma bias and normalized CB1 protein levels and im

59 emical results suggest that both Galphao and Gbetagamma bind TRPM1 channels and cooperate to close th

60 f GPA1, and XLG3 also competes with GPA1 for Gbetagamma binding in yeast.

61 phobic face of the PLC-beta PH domain as the Gbetagamma binding interface.

62 emonstrate that the PH domain is the minimal Gbetagamma binding region in PLC-beta3.

63 , there is a lack of consensus regarding the Gbetagamma binding site in PLC-beta.

64 The structural data indicated that the PIP3/Gbetagamma binding sites are on the opposite surface and

65 Loss of Gbetagamma binding to p101 caused more variable effects,

66 rated mice with point mutations that prevent Gbetagamma binding to p110gamma (RK552DD) or to p101 (VV

67 Loss of Gbetagamma binding to p110gamma substantially reduced th

68 Importantly, NF023 did not disrupt Galphai-Gbetagamma binding, indicating its specificity toward Ga

69 tating conformational rearrangement to allow Gbetagamma binding.

70 Specifically, a Gbetagamma-binding/activating peptide, mSIRK, increases

71 with soluble SNARE complexes have shown that Gbetagamma binds to both ternary SNARE complexes, t-SNAR

72 We now show that Gbetagamma binds to the NT of a wide variety of AC isofo

73 -ACh receptor interaction, and that not only Gbetagamma but also Galphaq can target GRK2 to the membr

74 nly significantly disrupt PM localization of Gbetagamma but also perturb GPCR-G protein signaling and

75 mpete with full-length PLC-beta3 for binding Gbetagamma but not Galphaq, Using sequence conservation,

76 alysis suggests a maximal stoichiometry of 4 Gbetagamma but only 2 Galphai/o per one GIRK1/2 channel.

77 Ggamma underlies membrane targeting of Gbetagamma, but has not been implicated in channel gatin

78 ation of Ser-485, which was mediated by G(i)/Gbetagamma, but not by Akt or S6K, two kinases that cont

79 Co-expression of Gbetagamma, but not constitutively active Galphai or Gal

80 tent with recruitment to the cell surface of Gbetagamma, but not Galpha, by GIRK1/2.

81 This dependence of Gi-Gbetagamma-Ca(2+) on Galpha(q) places an entire signalin

82 ologically inhibited or genetically ablated, Gbetagamma can bind to PLCbeta but does not elicit Ca(2+

83 The persistent Gbetagamma/channel (but not Galpha/channel) ratio suppor

84 endent Rac exchange factor 1 (P-REX1), a key Gbetagamma chemotactic effector, is directly controlled

85 G257284, and CCG258748) in complex with GRK2-Gbetagamma Comparison of these structures with those of

86 In turn, the Gbetagamma complex signals through phosphoinositide 3-ki

87 ecrease in interactions between DRD3 and the Gbetagamma complex, which is consistent with receptor ac

88 tions between the dopamine receptors and the Gbetagamma complex.

89 ges in the interactions between DRD2 and the Gbetagamma complex.

90 support a strong association of GIRK1/2 with Gbetagamma, consistent with recruitment to the cell surf

91 other retinal neurons, it is unknown whether Gbetagamma contributes to these effects.

92 and find an unexpected role for Galpha(q) in Gbetagamma-dependent activation of phospholipase Cbeta (

93 terologously expressed GIRK1/2 exhibit high, Gbetagamma-dependent basal currents (Ibasal) and a modes

94 results in DAT-mediated DA efflux through a Gbetagamma-dependent mechanism.

95 Galpha(13)-mediated signaling to Rho over a Gbetagamma-dependent Rac pathway, attributed to heterotr

96 ized by G protein-coupled receptors (GPCRs), Gbetagamma-dependent signaling cascades contribute to sp

97 atins, influence subcellular distribution of Gbetagamma dimer and Galphabetagamma heterotrimer, as we

98 Specifically, genetic ablation of the Gbetagamma dimer or loss of the full set of atypical Gal

99 GIRKs are activated by binding of the Gbetagamma dimer, via contacts with Gbeta.

100 ors and disrupt Galpha interactions with the Gbetagamma dimer.

101 Formation of the G-protein betagamma (Gbetagamma) dimer is particularly challenging because it

102 We demonstrate that the XLGs can bind Gbetagamma dimers (AGB1 plus a Ggamma subunit: AGG1, AGG

103 t channel expression levels, between 3 and 4 Gbetagamma dimers are available for each GIRK1/2 channel

104 erved interaction of the XLGs with all three Gbetagamma dimers at the plasma membrane in planta by bi

105 We show here that Gbetagamma directly binds to a domain of 10 amino acids

106 NARE interaction and show that the target of Gbetagamma, downstream of VGCC, is the membrane-embedded

107 sin and shed new light on the role played by Gbetagamma during receptor-catalyzed nucleotide exchange

108 ents, aberrant overexpression of chemotactic Gbetagamma effectors and recently identified mutations i

109 nucleotide exchange factor, are fundamental Gbetagamma effectors in the pathways controlling directi

110 to every known major binding partner [GPCRs, Gbetagamma, effectors, guanine nucleotide dissociation i

111 rrents, and surface densities of GIRK1/2 and Gbetagamma expressed in Xenopus oocytes.

112 ntly labeled syt1 undergoes competition with Gbetagamma for SNARE-binding sites in lipid environments

113 Inhibitors of PKD (CRT0066101) and Gbetagamma (gallein) prevented PAR2-stimulated activatio

114 cellular signal-regulated kinases 1 and 2 by Gbetagamma, Galpha(q/11), and Galpha(i/o)-independent me

115 f tetrameric Gbetagamma-Galpha(q)QL-RGS2 and Gbetagamma-Galpha(13-i2)QL-RGS4 complexes, whereas Galph

116 Moreover, Gbetagamma was part of tetrameric Gbetagamma-Galpha(q)QL-RGS2 and Gbetagamma-Galpha(13-i2)

117 In the presence of Gbetagamma, GIRK2 opens as a function of PIP2 mole fract

118 ion between the G-protein betagamma-subunit (Gbetagamma), GPCR-kinase 2, and beta-arrestin are centra

119 ng affinity toward Galphaq [GRK2(D110A)] and Gbetagamma [GRK2(R587Q)] were used to determine the spec

120 This study investigated the hypothesis that Gbetagamma-GRK2 inhibition and/or ablation after myocard

121 ng HF and the potential therapeutic role for Gbetagamma-GRK2 inhibition in limiting pathological myof

122 the understanding of the therapeutic role of Gbetagamma-GRK2 inhibition in treating HF and the potent

123 Systemic small molecule Gbetagamma-GRK2 inhibition initiated 1 week post-I/R in

124 Systemic small molecule Gbetagamma-GRK2 inhibition initiated 1 week post-I/R pro

125 Small molecule Gbetagamma-GRK2 inhibition initiated 1 week post-injury

126 Finally, Gbetagamma-GRK2 inhibition significantly attenuated acti

127 The therapeutic potential of small molecule Gbetagamma-GRK2 inhibition, alone or in combination with

128 hough many chemotaxis pathways downstream of Gbetagamma have been identified, few Galpha effectors ar

129 Thus, XLG-Gbetagamma heterotrimers provide additional signaling mo

130 betagamma subunits from activated Galpha(i)-Gbetagamma heterotrimers.

131 This contrasts with AC6, where the Gbetagamma hotspot is required for both interactions wit

132 Mutations of the Gbetagamma "hotspot" show that this site is necessary fo

133 (13)QL variants formed stable complexes with Gbetagamma, impairing its interaction with P-REX1.

134 Cross-linked PLC-beta does not bind Gbetagamma in a FRET-based Gbetagamma-PLC-beta binding a

135 Our results reveal a major role for PKD and Gbetagamma in agonist-evoked mobilization of intracellul

136 all, our data support a direct role for GPCR-Gbetagamma in AKI and suggest GPCR-Gbetagamma inhibition

137 , endosomes serve as signaling platforms for Gbetagamma In preclinical murine models of cancer, inhib

138 ), can reduce cone synaptic transmission via Gbetagamma in tiger salamander retinas.

139 a symmetric interaction with five copies of Gbetagamma in which the G-protein subunits also interact

140 alternative binding partners for Galpha and Gbetagamma independently of the classic heterotrimeric G

141 pendent reduction in ICa was not mimicked by Gbetagamma, indicating that this effect was independent

142 Here we show that Gbetagamma induces the release of DA through DAT.

143 ength t- and v-SNAREs embedded in liposomes, Gbetagamma inhibited Ca(2+)/synaptotagmin-dependent fusi

144 for GPCR-Gbetagamma in AKI and suggest GPCR-Gbetagamma inhibition as a novel therapeutic approach fo

145 Gbetagamma inhibition blocked ET-1-stimulated Golgi PI4P

146 Notably, systemic pharmacologic Gbetagamma inhibition by gallein, which we previously sh

147 d the possible salutary effect of renal GPCR-Gbetagamma inhibition in CKD developed in a clinically r

148 -stimulated hypertrophy, and the efficacy of Gbetagamma inhibition in preventing heart failure maybe

149 Our results identify Gbetagamma inhibition of TRPM3 as an effector mechanism

150 in betagamma subunits was shown by using the Gbetagamma inhibitor gallein and the direct activation o

151 Addition of the Gbetagamma inhibitor gallein or DAT inhibitors prevents

152 PKD and Gbetagamma inhibitors also attenuated protease-evoked me

153 G-protein betagamma subunits (Gbetagamma) interact with presynaptic proteins and regul

154 The 10-amino-acid Gbetagamma-interacting domain in TRPM3 is subject to alt

155 A TAT peptide containing the Gbetagamma-interacting domain of DAT blocked the ability

156 of the protein interface required for Galpha-Gbetagamma interaction (resulting in a constitutively ac

157 d Ca(2+) release that is likely dependent on Gbetagamma interaction with PLCs leading to InsP3 produc

158 Consistent with G protein betagamma (Gbetagamma) interaction, modulation of Cav2.2 was primar

159 ons on the role of CaMKII-Gbetagamma and CaN-Gbetagamma interactions in mediating hypertrophic signal

160 by triggering G-protein betagamma subunits (Gbetagamma) interactions with SNAP-25, a core component

161 ith both the N- and the C- termini of TRPM1, Gbetagamma interacts only with the N-terminus.

162 ironment, we show that fluorescently labeled Gbetagamma interacts specifically with lipid-embedded t-

163 Collectively, our data show that Gbetagamma interacts with DAT to promote DA efflux.

164 In addition, Gbetagamma interacts with the C-terminal tail of GPR124

165 We further show that KCTD binding to Gbetagamma is highly cooperative, defining a model in wh

166 In addition, we found that Gbetagamma is required for the Wnt-5a-mediated increase

167 Gbetagamma liberated from other photoreceptor GPCRs is a

168 cells and sensory neurons inhibits TRPM3 via Gbetagamma liberation.

169 A less understood Gbetagamma-mediated mechanism downstream of Ca(2+) entry

170 and physiological relevance of the two known Gbetagamma-mediated mechanisms for presynaptic inhibitio

171 In addition to Gbetagamma-mediated modulation of voltage-gated calcium

172 in contrast to M119/Gallein had no effect on Gbetagamma-mediated phospholipase C or phosphoinositide

173 of RasGEF and Ric8, while globally-diffusing Gbetagamma mediates their activation.

174 transduced Gbetagamma-protein kinase C- and Gbetagamma-metalloproteinase/EGFR-dependent MAPK/ERK sig

175 presynaptic inhibition: first, the action of Gbetagamma on voltage-gated calcium channels to inhibit

176 hosducin or inactive Galphao (both sequester Gbetagamma) opened the channel while the active mutant o

177 p110gamma, receive direct regulation through Gbetagamma or indirect regulation through RAS and the su

178 action (resulting in a constitutively active Gbetagamma) or through the disruption of residues releva

179 t specifically abolishes PI3Kbeta binding to Gbetagamma (p110(526KK-DD)).

180 rin signals into proinvasive responses via a Gbetagamma-PI3K axis.

181 These results suggest that Gbetagamma/PKC-dependent ERK1/2 activation and heterolog

182 eta does not bind Gbetagamma in a FRET-based Gbetagamma-PLC-beta binding assay.

183 We find that the Galpha(i)-Gbetagamma-PLCbeta-Ca(2+) signaling module is entirely d

184 ate binding domains do not affect GPER/GPR30-Gbetagamma preassociation but decrease GPER/GPR30-mediat

185 t the dynamic spatiotemporal balance between Gbetagamma-promoted adhesion and Galphai-GTP reversal of

186 RPM3 is subject to promiscuous inhibition by Gbetagamma protein in heterologous expression systems, p

187 e dialyzed with GRK2i, which sequesters free Gbetagamma protein, TRPM3 inhibition by EP2 and BK2 was

188 by preventing binding to the receptor-linked Gbetagamma protein.

189 uding G proteins (Galphas, Galphai, Galphao, Gbetagamma), protein kinases (PKCbetaII, CaMKII), and fo

190 ization of TRPA1 by mechanisms that required Gbetagamma, protein kinase C, and Ca(2+).

191 e stimulation of MOR activates a Galpha(i/o)-Gbetagamma-protein kinase C (PKC) alpha phosphorylation

192 hat HCA2 in A431 epithelial cells transduced Gbetagamma-protein kinase C- and Gbetagamma-metalloprote

193 -immunoprecipitated with Gbeta, and purified Gbetagamma proteins applied to excised inside-out patche

194 Since Gbetagamma proteins can be liberated from other Galpha s

195 itching on or off the inhibitory action that Gbetagamma proteins exert on TRPM3 channels.

196 ed within their C-terminal binding sites for Gbetagamma proteins that mediate membrane-delimited GIRK

197 u-opioid receptors through the signaling of Gbetagamma proteins, thereby reducing TRPM3-mediated pai

198 curs via a short signaling cascade involving Gbetagamma proteins, which form a complex with TRPM3.

199 ude that G1-dCT carries an essential role in Gbetagamma recruitment by GIRK1 and, consequently, in de

200 We propose Gbetagamma regulation of AC involves multiple binding ev

201 itionally, the SIGK hotspot peptide disrupts Gbetagamma regulation of AC isoforms 1, 2, and 6, but no

202 These data indicate that Gbetagamma regulation of the perinuclear Golgi PI4P path

203 te that TRPM3 channels are also inhibited by Gbetagamma released from Galpha(s) and Galpha(q) Activat

204 model whereby P-Rex1 binding to PIP3 and/or Gbetagamma releases inhibitory C-terminal domains to exp

205 ed is proportional to the fractional loss of Gbetagamma response.

206 y to CHF associated with elevated renal GPCR-Gbetagamma signaling and ET system expression.

207 Since Ggamma is required for Gbetagamma signaling and shows a cell- and tissue-specif

208 Taken together, these data suggest that Gbetagamma signaling contributes to the maintenance and

209 Here we discuss emerging paradigms of Gbetagamma signaling in cancer, which are essential for

210 ro studies showed a key role for ET receptor-Gbetagamma signaling in pathologic fibroblast activation

211 e authors propose simultaneous inhibition of Gbetagamma signaling in the heart and the adrenal gland

212 Here, we investigated whether Gbetagamma signaling to phosphatidylinositol 3,4,5-trisp

213 ght in turn favor Rho pathways by preventing Gbetagamma signaling to Rac.

214 i expression, pharmacologically interrupting Gbetagamma signaling, or reducing Elmo1 expression all i

215 ct binding of G protein beta-gamma subunits (Gbetagamma), signaling lipids, and intracellular Na(+).

216 This inhibition was prevented when the Gbetagamma sink betaARK1-ct (C terminus of beta-adrenerg

217 sion at cone ribbon synapses is regulated by Gbetagamma/SNAP-25 interactions indicates that these mec

218 , this provides the first demonstration that Gbetagamma/SNAP-25 interactions regulate synaptic functi

219 s inhibited by BoNT/A, supporting a role for Gbetagamma/SNAP-25 interactions.

220 rate the importance of these regions for the Gbetagamma-SNARE interaction and show that the target of

221 ocytosis by G(i/o)-coupled GPCRs through the Gbetagamma-SNARE interaction is a crucial component of n

222 minus of SNAP25 is a critical region for the Gbetagamma-SNARE interaction.

223 ng to an emerging picture of the ubiquity of Gbetagamma/SNARE interactions in regulating synaptic tra

224 However, in secretory cells, Gbetagamma, SNAREs, and synaptotagmin interact in the li

225 Coexpression of Gbetagamma-specific scavengers-namely, the carboxyl term

226 d with epinephrine to understand the role of Gbetagamma specificity in diverse physiological function

227 Here, we examined the in vivo Gbetagamma specificity of presynaptic alpha(2a)-adrenerg

228 Further understanding of in vivo Gbetagamma specificity to various GPCRs offers new insig

229 n of cAMP/PKA signaling, whereas reversal of Gbetagamma-stimulated adhesion was cAMP/PKA independent.

230 ac1 binding, basal lipid kinase activity, or Gbetagamma-stimulated kinase activity.

231 n with Norbin increases the basal, PIP3- and Gbetagamma-stimulated Rac-GEF activity of P-Rex1.

232 ractions involving inactive heterotrimer and Gbetagamma stimulation of AC5 were separable events.

233 v7 channel currents in the absence of either Gbetagamma subunit enrichment or G-protein-coupled recep

234 gallein and two other structurally different Gbetagamma subunit inhibitors (GRK2i and a beta-subunit

235 GIRK1-4), activated by direct binding of the Gbetagamma subunit of Gi/o proteins.

236 annel activity through direct binding of the Gbetagamma subunit to the channel.

237 In excised patch recordings, Gbetagamma subunits (2-250 ng /mL) enhanced the open pro

238 hat in addition to their LE activities, free Gbetagamma subunits also govern TE retraction by operati

239 signaling but rather involves liberation of Gbetagamma subunits and activation of calcium channels.

240 t TRPM3 through a direct interaction between Gbetagamma subunits and TRPM3.

241 These results reveal that Gbetagamma subunits are fundamental for Kv7.4 activation

242 Using this assay we show that four Gbetagamma subunits bind cooperatively to open GIRK2, an

243 Depending on the AC isoform, Gbetagamma subunits can either conditionally stimulate o

244 imity ligation assay revealed that Kv7.4 and Gbetagamma subunits colocalized in HEK cells and renal a

245 gated K+ channels (GIRK; Kir3), activated by Gbetagamma subunits derived from Gi/o proteins, regulate

246 Introducing Gbetagamma subunits directly into cones reduced EPSC amp

247 between p101/p110gamma and p84/p110gamma for Gbetagamma subunits downstream of GPCR activation.

248 Release of Gbetagamma subunits from activated G proteins decreases

249 Furthermore, mSIRK, which disassociates Gbetagamma subunits from alpha subunits without stimulat

250 activity and mediated by membrane-delimited Gbetagamma subunits in a voltage-independent manner.

251 These findings define a direct role for Gbetagamma subunits in activating both of the endogenous

252 66 Galphas mutants) that are unable to bind Gbetagamma subunits in cells.

253 aled direct interactions between SNAP-25 and Gbetagamma subunits in retinal synaptic layers.

254 , as a direct effector of GPCR signaling via Gbetagamma subunits in the striatum.

255 tivated pathways, and the well characterized Gbetagamma subunits inhibit Cav2.2 currents.

256 elective cation channel that is inhibited by Gbetagamma subunits liberated following activation of Ga

257 e second messenger PIP3, (ii) binding of the Gbetagamma subunits of heterotrimeric G proteins, and (i

258 ed and used to estimate the concentration of Gbetagamma subunits that appear in the membrane of mouse

259 Mutant Gbetagamma subunits that were previously shown to be mor

260 These mutant Gbetagamma subunits were unable to inhibit VGCC currents

261 e mediated through the direct interaction of Gbetagamma subunits with the soluble N-ethylmaleimide at

262 rotrimeric G-proteins (comprising Galpha and Gbetagamma subunits) are critical for coupling of metabo

263 ivation by the Gq family of Galpha subunits, Gbetagamma subunits, and some Rho family GTPases, phosph

264 gulated via interactions with heterotrimeric Gbetagamma subunits, PIP(3), and protein kinase A (PKA).

265 Gallein, an inhibitor of Gbetagamma subunits, prevented these stimulatory effects

266 re mediated by direct inhibition of TRPM3 by Gbetagamma subunits, rather than by a canonical cAMP med

267 rotein inhibition by co-expressed Trichoplax Gbetagamma subunits, which nevertheless inhibited the hu

268 via the canonical heterotrimeric Galpha and Gbetagamma subunits.

269 kDa (SNAP25) is a key downstream effector of Gbetagamma subunits.

270 a(T) helical domain (alphaHD) contacting the Gbetagamma subunits.

271 mechanisms underlying GPCR signaling through Gbetagamma subunits.

272 gical signaling through G protein betagamma (Gbetagamma) subunits and their interaction with G protei

273 recently reported that G-protein beta-gamma (Gbetagamma) subunits bind directly to DAT and decrease D

274 pled receptors (GPCRs), G protein betagamma (Gbetagamma) subunits control the LE signaling.

275 a permanent state of high responsiveness to Gbetagamma, suggesting that the GIRK1 subunit functions

276 iosensors for endogenous Galpha-GTP and free Gbetagamma: the two active species of heterotrimeric G-p

277 by botulinum toxin A reduces the ability of Gbetagamma to compete with the calcium sensor synaptotag

278 lexes, whereas Galpha(13)QL dissociated from Gbetagamma to interact with the PDZ-RhoGEF-RGS domain.

279 We find that binding of Gbetagamma to NF1 inhibits its ability to inactivate Ras

280 downstream of Ca(2+) entry is the binding of Gbetagamma to SNARE complexes, which facilitate the fusi

281 mall peptides interfered with the binding of Gbetagamma to the GlyR and consequently inhibited the et

282 Translocation of Gbetagamma to the Golgi stimulated perinuclear Golgi PI4

283 timulated translocation of the PKD activator Gbetagamma to the Golgi, coinciding with PAR(2) mobiliza

284 channels, but not GIRK2 homomers, recruited Gbetagamma to the plasma membrane.

285 tive zone and, second, the direct binding of Gbetagamma to the SNARE complex to displace synaptotagmi

286 e contribution of protein kinase D (PKD) and Gbetagamma to this process.

287 ed receptors is well known to be mediated by Gbetagamma together with negatively charged membrane pho

288 The results show that differential Gbetagamma translocation rates can underlie the diversit

289 and the cooperative nature of GIRK gating by Gbetagamma, underlie the complex pattern of basal and ag

290 that chimeric Galpha(13-i2)QL interacts with Gbetagamma unlike to Galpha(i2-13)QL, the reciprocal chi

291 Moreover, Gbetagamma was part of tetrameric Gbetagamma-Galpha(q)QL

292 ion of Rac1 by the second messengers PIP3 or Gbetagamma, we found that PREX2 was phosphorylated throu

293 -triggered exocytotic release than wild-type Gbetagamma were also shown to bind SNAREs at a higher af

294 Gbetagamma, when dialysed into cells, failed to activate

295 bolishes interaction with Galphaq as well as Gbetagamma while having no effect on receptor synthesis,

296 ant that is deficient in its ability to bind Gbetagamma while retaining normal calcium-dependent Syt1

297 x formation with Ggamma and resultant mutant Gbetagamma with Galpha.

298 wn to be mediated through the interaction of Gbetagamma with SNAP25.

299 lux, consistent with a direct interaction of Gbetagamma with the transporter.

300 o the EF hand domain inhibits stimulation by Gbetagamma without altering basal activity or Galphaq re